Skip to main content

JDRF is undergoing a transformation.
We are becoming Breakthrough T1D in October.

breakthrought1d logo
Filters
Topics
Apply
Read more
A researcher sits in a lab beside screening samples and lab equipment for early detection of type 1 diabetes.
Policy and advocacy Research
24 June 2024

New guidance sets out how to support people with early-stage type 1 diabetes

New international guidance detailing how to monitor and support people with early-stage type 1 diabetes (T1D) has the potential to reduce the trauma associated with being diagnosed with T1D, enable people to access the latest treatments to delay the need for insulin therapy, and reduce long-term health complications.

Read more
James Norton sitting in an armchair holding a teddy that has a CGM on it's arm. There is a plush woolly mammoth next to him.
Awareness Celebrities Living with type 1
10 June 2024

James Norton to read CBeebies bedtime story about type 1 diabetes

JDRF ambassador James Norton will read a CBeebies Bedtime Story this Diabetes Awareness Week to help young children understand type 1 and how it can be managed

Read more
Breakthrough T1D, formally JDRF
JDRF
4 June 2024

JDRF UK to become Breakthrough T1D in major international rebrand

The leading global type 1 diabetes charity, JDRF International (JDRF) is proud to unveil its new brand and name, Breakthrough T1D. The new name embodies its mission to cure and treat type 1 diabetes (T1D), while supporting everyone who lives with the condition.

Read more
A row of vials of clear liquid with black lids. A blue gloved hand is pinching the top of the closest vial as if to pick it up.
Research Treatment research
13 May 2024

Novel insulin being developed to enable implantable insulin pumps

Medtronic Diabetes have announced they are funding the biopharmaceutical company Arecor Therapeutics to develop a novel, highly concentrated, thermostable insulin, which will be specialised for use in implantable insulin pumps.

Read more
Professor Colin Dayan at Cardiff University, working on immunotherapy for type 1 diabetes cure research
Cure research Prevention research Research Treatment research
18 April 2024

Professor Colin Dayan presented with the 2023 JDRF Rumbough Award 

The award recognises Professor Dayan’s remarkable accomplishments in type 1 diabetes research.

Read more
Two young children sat on the floor hugging each other.
Research
18 April 2024

Genetically unique siblings reveal new treatment target for type 1 diabetes

Two siblings who have unique changes in a key gene have given researchers new insights that could help lead to innovative new treatments in type 1 diabetes.

Read more
A female doctor works at a laptop on a table. She is wearing a shirt and glasses with a stethoscope around her neck.
Prevention research
17 April 2024

New international medical code launches for presymptomatic type 1 diabetes

JDRF-funded researchers from the University of Birmingham have joined forces with NHS England to develop a diagnostic code for use on electronic medical records of people in the earliest stages of type 1 diabetes, allowing them to receive better, more timely healthcare and access to emerging treatments.

Read more
Living with type 1
25 March 2024

Coping with Diabetes: a new emotional support tool for young people with type 1

JDRF and Digibete have teamed up to create Coping with Diabetes, a new interactive support tool to help children and young people with type 1 look after their mental health and wellbeing.

Read more
Professor Richard Oram in the Research, Innovation, Learning and Development (RILD) building at the University of Exeter.
Prevention research Research Treatment research
7 March 2024

New biochip launches that detects genetic risk of type 1 diabetes

A new test by Randox, developed with JDRF-funded researchers at the University of Exeter, is the first in the world to use genetics to quickly identify who is at high risk of developing type 1 diabetes.

Read more
A graphic of a DNA double helix with a piece being removed demonstrating genetic engineering.
Cure research Research
21 February 2024

Primate with type 1 diabetes becomes insulin-independent after receiving gene-edited cells without immunosuppression

A transplant of stem cells grown into pancreatic islets has allowed a primate with type 1 to make its own insulin again.

Read more
A photo of a room full of people sat at chairs facing presenters and screens.
Complications
13 February 2024

Diabetes and kidney research charities team up to tackle diabetic kidney disease

Diabetes is the leading cause of kidney disease in the UK, so we've joined forces with Diabetes UK, and Kidney Research UK to identify the research gaps and care needs in the field.

Read more
A profile photo of type 1 diabetes prevention researcher, Professor Claire Meek.
Prevention research
13 February 2024

JDRF and Helmsley Trust funding leads global research push to prevent type 1 diabetes

JDRF and the Helmsley Charitable Trust have announced over £1.5 million in joint funding for five international researchers – including one UK-based researcher – to access unique data sources and unravel how type 1 diabetes develops, with the goal of preventing the condition.

Read more
Policy and advocacy
1 February 2024

Our letter to the producers of Would I Lie to You?

We wrote to the producers of the hit BBC show after they broadcast jokes about type 1 diabetes.

Read more
A small container containing three tablets of a novel glucose-responsive oral insulin.
Research Treatment research
29 January 2024

Early research shows glucose-responsive insulin tablets are safe and effective in animals

Researchers have developed a new oral insulin that travels in an inactive state to the liver and is only activated by rising blood glucose levels.

Read more
A doctor talking to a young woman holding a pen
Policy and advocacy
23 January 2024

Parliamentary Inquiry calls for urgent action on type 1 and disordered eating

Parliamentary Inquiry chaired by our Global Health Ambassador, Rt. Hon Theresa May MP and Sir George Howarth MP, highlights the risks of type 1 diabetes-related eating disorders (T1DE).

Read more
Researcher Safiya Naina Marikar pipetting in the lab.
Cure research Research
2 January 2024

Research breakthrough shows insulin-producing cells can be regenerated

We could be one step closer to replacing the need for regular insulin injections in people living with type 1 diabetes, thanks to JDRF-funded research in Australia published this week in the Nature journal.

Read more
The Rt. Hon Theresa May MP giving a reading at St Paul's Cathedral
Celebrities Events Fundraising
20 December 2023

Musicians and familiar faces attend charity carol concert at St Paul’s Cathedral

Last night JDRF teamed up with the Royal Osteoporosis Society to host a charity carol concert at St Paul’s Cathedral. The event featured a lineup of familiar faces, including The Rt. Hon Theresa May MP and Derrick Evans MBE.

Read more
Hybrid closed loop technology
Research Treatment research Treatments Type 1 technology
19 December 2023

NICE Approves hybrid closed loop for the majority of people living with type 1 diabetes in England and Wales

In an historic advancement in the treatment of type 1 diabetes, the National Institute for Health and Care Excellence (NICE) today approves hybrid closed loop for the majority of people living with type 1 diabetes in England and Wales.

Read more
ELSA testing kits to screen for type 1 diabetes in children
Prevention research Research
12 December 2023

£20 million type 1 diabetes screening project co-funded by JDRF launches in Europe

EDENT1FI aims to develop a population screening programme for type 1, revolutionising how the condition is diagnosed and managed.

Read more
Dr Gavin Bewick, a type 1 diabetes researcher working on developing a drug to protect beta cells, in his lab.
JDRF Research
12 December 2023

2023 in review – a year of progress and breakthroughs

It's been an incredible year for advancements in type 1 diabetes research and treatments. We take a look at the progress we made in 2023, funded by you, our supporters. 

Read more
Dr Ana Cruz in her lab
Research
11 December 2023

JDRF UK supports first-of-its-kind sex and gender policy for research

We support the introduction of dedicated sex and gender policies in UK research, which will encourage scientists to think about sex and/or gender in their research.

Read more
Juvenile Arthritis Research logo
Prevention research Research
8 December 2023

New autoimmune research charity joins the Connect Immune Research partnership

The newest member of our innovative autoimmune research initiative, Connect Immune Research, is Juvenile Arthritis Research.

Read more
A woman researcher at work in a lab
Clinical trials Research
7 December 2023

World-first clinical trial finds drug can suppress progression of type 1 diabetes in people newly diagnosed

World-first clinical trial finds drug can suppress progression of type 1 diabetes in people newly diagnosed

Read more
Nina Willer, who used hybrid closed loop technology through pregnancy, and her child.
Policy and advocacy Treatment research Treatments Type 1 technology
7 November 2023

Hybrid closed loop technology set to be made available in England and Wales

The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.

Read more
T cell immune system
Research Treatment research Treatments
6 November 2023

New research highlights the effectiveness of immune therapies for type 1 diabetes

The research, which was co-funded by JDRF, reveals that drugs that target the immune system offer very effective and rapid improvements in stabilising blood sugar levels, often within just three months.

Read more
Dr Ify Mordi, lead type 1 diabetes researcher
Complications Treatment research
25 October 2023

JDRF award £1.5 million grant to University of Dundee for type 1 diabetes clinical trial

The new JDRF-funded clinical trial called SOPHIST will test a drug to help people with type 1 diabetes and heart failure.

Read more
Young person receiving an injection of the immunotherapy drug teplizumab.jpg
Clinical trials Prevention research Research
18 October 2023

Clinical trial finds teplizumab slows type 1 diabetes in people newly diagnosed 

Results from a clinical trial called the PROTECT study show that teplizumab can preserve beta cell function in children and adolescents newly diagnosed with type 1 diabetes.

Read more
ELSA testing kits to screen for type 1 diabetes in children
Clinical trials Prevention research Research
16 October 2023

Trial to screen children for type 1 diabetes now available in Northern Ireland

Children in Northern Ireland are now eligible for a trial screening programme that will identify those at high risk of developing type 1 diabetes in the future.

Read more
A hand holding a plastic model of a kidney
Clinical trials Complications Research Treatment research
13 October 2023

JDRF commits £1.3 million to investigate medication with the potential to delay kidney complications

Thanks to JDRF supporters, we’ve been able to award a £1.3 million grant to King’s College London (KCL) and Steno Diabetes Center Copenhagen to examine how existing drugs, known as SGLT inhibitors, could delay the progression of kidney disease in people living with type 1 diabetes.

Read more
A woman with type 1 diabetes who is discussing pregnancy with a nurse
Research
5 October 2023

New trial shows benefits of hybrid closed loop in pregnancy  

A JDRF-supported trial published in the New England Journal of Medicine and presented at the European Association for the Study of Diabetes conference has shown that hybrid closed loop technology helps pregnant women better manage their blood sugars compared to traditional insulin pumps or multiple daily injections.  

Read more
A graph from the research paper showing that the people with type 1 diabetes who took the antiviral drugs had higher levels of C-peptide (insulin production) than those on the placebo.
Clinical trials
5 October 2023

Antiviral drugs could maintain beta cell function in children newly diagnosed with type 1 diabetes

A clinical trial funded by JDRF suggests that treating children with antiviral drugs when they are first diagnosed with type 1 diabetes could preserve their ability to produce some insulin.

Read more
Aaron Kowalski (JDRF International CEO), Karen Addington (JDRF UK CEO) and Professor Roman Hovorka
Research
4 October 2023

Professor Roman Hovorka wins prestigious award at Europe’s largest diabetes conference

Professor Roman Hovorka, who JDRF has funded since 2006 to develop hybrid closed loop (HCL) technology, has won this year’s EASD-Novo Nordisk Foundation Diabetes Prize for Excellence.

Read more
A young guy with type 1 diabetes dealing with exam stress and taking an exam
Policy and advocacy
4 October 2023

Letter to Gillian Keegan about the use of mobile phones in schools

We’ve written a letter to Gillian Keegan MP, Secretary of State for Education, asking her to make exemptions to the Government’s policy on banning mobile phones in schools. We thought you might like to read it.

Read more
Close up of someone kneeling down and tying the shoelace on their trainer whilst on a running track
Living with type 1 Research
27 September 2023

People with type 1 diabetes held back from sport due to stigma and fear of hypos

Our survey has shown that half of people with type 1 diabetes feel that the condition holds them back from physical activity and exercise.

Read more
Illustration of the hybrid closed loop technology system, funded as part of treatment research for type 1 diabetes by JDRF.
Policy and advocacy Type 1 technology
21 August 2023

NICE’s latest consultation on hybrid closed loop

As part of its assessment of hybrid closed loop (HCL), the National Institute for Health and Care Excellence (NICE) has today published an additional consultation on its roll out.

Read more
Researcher Safiya Naina Marikar pipetting in the lab.
Cure research Treatment research
12 July 2023

JDRF-funded researchers make pancreatic ductal cells sense and release insulin

In a JDRF-funded research project in Australia, scientists have turned human pancreatic ductal cells into insulin-producing cells, offering promise for restoring the ability to make insulin in people living with type 1 diabetes.

Connect with us on social